Jounce Therapeutics, Inc.

JNCE · NASDAQ
Analyze with AI
12/31/2022
9/30/2022
6/30/2022
3/31/2022
Assets
Cash & Equivalents$150,572$77,111$77,741$60,412
Short-Term Investments$38,970$51,498$70,823$95,006
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$7,689$11,321$8,783$9,418
Total Curr. Assets$197,231$139,930$157,347$164,836
Property Plant & Equip (Net)$12,317$13,366$14,677$15,532
Goodwill$0$0$0$0
Intangibles$0$0$0$0
Long-Term Investments$0$1,723$13,691$30,977
Tax Assets$0$0$0$0
Other NC Assets$3,002$3,062$3,186$3,326
Total NC Assets$15,319$18,151$31,554$49,835
Other Assets$0$0$0$0
Total Assets$212,550$158,081$188,901$214,671
Liabilities
Payables$2,095$1,115$3,439$1,903
Short-Term Debt$4,150$4,024$3,912$3,802
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$17,323$16,658$15,844$10,997
Total Curr. Liab.$23,568$21,797$23,195$16,702
LT Debt$5,870$6,926$7,976$9,006
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$0$0$0$0
Total NC Liab.$5,870$6,926$7,976$9,006
Other Liabilities$0$0$0$0
Cap. Leases$10,020$10,950$11,888$12,808
Total Liabilities$29,438$28,723$31,171$25,708
Equity
Pref Stock$0$0$0$0
Common Stock$51$51$51$51
Retained Earnings-$292,792-$343,751-$312,753-$279,240
AOCI-$677-$1,031-$1,097-$901
Other Equity$476,530$474,089$471,529$469,053
Total Equity$183,112$129,358$157,730$188,963
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$212,550$158,081$188,901$214,671
Net Debt-$140,552-$66,161-$65,853-$47,604
Jounce Therapeutics, Inc. (JNCE) Financial Statements & Key Stats | AlphaPilot